Portfolio concentration
As of February 27, 2026 · N-PORT
Holdings
51
Top-10 weight
54.28%
Effective holdings
?
The number of equal-weight positions that would produce this portfolio's concentration (1 ÷ Herfindahl index). A 500-stock fund dominated by a few mega-caps might have only ~100 effective holdings.
19
Crowding
?
The value-weighted average number of funds that also own this fund's positions. High = consensus/crowded picks; low = holdings few other funds own.
993.9
Holdings
As of February 27, 2026 · N-PORT| # | Security | Ticker | Shares | Value | % of fund |
|---|---|---|---|---|---|
| 1 | LILLY ELI and CO | — | 232,558 | $244.65M | 16.77% |
| 2 | (PIPA070) PGIM Core Government Money Market Fund | — | 112,597,990 | $112.60M | 7.72% |
| 3 | MERCK & CO | — | 708,913 | $87.78M | 6.02% |
| 4 | GILEAD SCIENCES INC | — | 427,773 | $63.72M | 4.37% |
| 5 | UNITEDHEALTH GRP | — | 214,171 | $62.81M | 4.31% |
| 6 | VERTEX PHARMACEUTICALS INC | — | 104,411 | $51.87M | 3.56% |
| 7 | CVS HEALTH CORP | — | 597,350 | $47.73M | 3.27% |
| 8 | LONZA GROUP -REG | — | 65,672 | $45.68M | 3.13% |
| 9 | ARGENX SE SPONSORED ADR | — | 59,035 | $45.28M | 3.10% |
| 10 | REGENERON PHARMACEUTICALS INC | — | 57,331 | $44.81M | 3.07% |
| 11 | DANAHER CORP | — | 210,865 | $44.42M | 3.04% |
| 12 | THERMO FISHER SCIENTIFIC INC | — | 78,063 | $40.68M | 2.79% |
| 13 | ROIVANT SCIENCES LTD | — | 1,022,182 | $29.58M | 2.03% |
| 14 | VAXCYTE INC | — | 463,089 | $28.59M | 1.96% |
| 15 | TEVA PHARMACEUTICAL IND ADR | — | 835,523 | $28.29M | 1.94% |
| 16 | BEONE MEDICINES LTD ADR | — | 87,672 | $27.79M | 1.90% |
| 17 | PALVELLA THERAPEUTICS INC | — | 183,037 | $24.71M | 1.69% |
| 18 | AGILENT TECHNOLOGIES INC | — | 202,903 | $24.63M | 1.69% |
| 19 | SIONNA THERAPEUTICS INC | — | 651,048 | $23.79M | 1.63% |
| 20 | SCHOLAR ROCK HOLDING CORP | — | 524,559 | $23.22M | 1.59% |
| 21 | PRUDENTIAL INVESTMENT PORTFOLIOS 2 PRUDENTIAL INSTITUTIONA 0.00000000 | — | 23,026,544 | $23.01M | 1.58% |
| 22 | EDWARDS LIFESCIENCES CORP | — | 263,382 | $22.77M | 1.56% |
| 23 | XENON PHARMACEUTICALS INC | — | 522,446 | $22.59M | 1.55% |
| 24 | INSMED INC | — | 133,269 | $19.90M | 1.36% |
| 25 | KYMERA THERAPEUTICS INC | — | 215,651 | $19.70M | 1.35% |
| 26 | NEWAMSTERDAM PHARMA COMPANY NV | — | 534,102 | $18.94M | 1.30% |
| 27 | APOGEE THERAPEUTICS INC | — | 240,387 | $16.83M | 1.15% |
| 28 | ASTRAZENECA PLC | — | 79,048 | $16.48M | 1.13% |
| 29 | Bayer Aktiengesellschaft | BAYN | 306,092 | $15.15M | 1.04% |
| 30 | CRINETICS PHARMACEUTICALS INC | — | 357,533 | $14.69M | 1.01% |
| 31 | VIRIDIAN THERAPEUTICS INC | — | 459,360 | $13.50M | 0.93% |
| 32 | DISC MEDICINE INC | — | 198,021 | $13.19M | 0.90% |
| 33 | TANDEM DIABETES CARE INC | — | 496,296 | $12.56M | 0.86% |
| 34 | APELLIS PHARMACEUTICALS INC | — | 594,859 | $12.47M | 0.85% |
| 35 | PROTAGONIST THERAPEUTICS INC | — | 135,272 | $12.46M | 0.85% |
| 36 | TARSUS PHARMACEUTICALS INC | — | 162,644 | $12.28M | 0.84% |
| 37 | MINERALYS THERAPEUTICS INC | — | 403,711 | $11.81M | 0.81% |
| 38 | CABALETTA BIO INC | — | 3,518,102 | $11.68M | 0.80% |
| 39 | ALIGN TECHNOLOGY INC | — | 60,913 | $11.58M | 0.79% |
| 40 | UCB SA | — | 36,522 | $10.97M | 0.75% |
| 41 | ARCUTIS BIOTHERAPEUTICS INC | — | 391,457 | $10.56M | 0.72% |
| 42 | REVOLUTION MEDICINES INC | — | 96,874 | $9.88M | 0.68% |
| 43 | OLEMA PHARMACEUTICALS INC | — | 344,618 | $8.34M | 0.57% |
| 44 | CELCUITY INC | — | 73,339 | $8.19M | 0.56% |
| 45 | IMMUNOVANT INC | — | 277,806 | $7.70M | 0.53% |
| 46 | TYRA BIOSCIENCES INC | — | 182,879 | $6.09M | 0.42% |
| 47 | LB PHARMACEUTICALS INC | — | 231,150 | $5.55M | 0.38% |
| 48 | Abivax SA SPONSORED ADS | ABVX US | 45,200 | $5.48M | 0.38% |
| 49 | COMPASS Pathways PLC, ADR | CMPS | 610,510 | $4.21M | 0.29% |
| 50 | UNIQURE N.V. | — | 228,413 | $3.57M | 0.24% |
1 / 2
Next ›
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.